MTRI Stock Analysis Today
Updated Nov 20, 2026 · trends, key levels, insider activity and news
Is MTRI bullish or bearish today?
Daily trend: Neutral
SEPT signal: Accumulation · Consolidating
Research grade: B+ · fair value $30.00 (+96.8%)
MTRI trend by timeframe
| Daily | Neutral |
|---|---|
| 4 hour | Strong Bearish |
| 1 hour | Strong Bearish |
| 15 min | Symmetric Triangle |
| 5 min | Strong Bearish |
Trends are calculated from price structure and update during market hours.
Latest MTRI news and filings
- AnalystBenzinga
Wedbush starts Mentari Therapeutics coverage with Outperform rating and $33 price target
Wedbush began covering Mentari Therapeutics with an Outperform rating. The firm set a $33 price target on the shares.
- AnalystBenzinga
Jefferies starts Mentari Therapeutics coverage with Buy rating and $30 price target
Jefferies began covering Mentari Therapeutics and gave the shares a Buy rating. The firm set a $30 price target on the stock.
- AnalystBenzinga
Stifel starts Mentari Therapeutics coverage with Buy rating and $30 price target
Stifel began covering Mentari Therapeutics and rated the shares Buy. The firm set a $30 price target on the stock.
Live MTRI chart with trend icons on every timeframe, key levels, dark pool and options flow, news alerts, and Ask GOAX for a full analysis on demand.
Start free 7-day trialFrequently asked questions
Is MTRI bullish or bearish today?
MTRI daily trend: Neutral. SEPT signal: Accumulation (Consolidating). Updated Nov 20, 2026.
What is MTRI's trend on each timeframe?
Daily: Neutral; 4 hour: Strong Bearish; 1 hour: Strong Bearish; 15 min: Symmetric Triangle; 5 min: Strong Bearish.
What is the latest news on MTRI?
Nov 13, 2026: Wedbush starts Mentari Therapeutics coverage with Outperform rating and $33 price target · Nov 10, 2026: Jefferies starts Mentari Therapeutics coverage with Buy rating and $30 price target · Nov 10, 2026: Stifel starts Mentari Therapeutics coverage with Buy rating and $30 price target